Energy metabolism disorders and potential therapeutic drugs in heart failure
Heart failure (HF) is a global public health problem with high morbidity and mortality. A large number of studies have shown that HF is caused by severe energy metabolism disorders, which result in an insufficient heart energy supply. This deficiency causes cardiac pump dysfunction and systemic ener...
Saved in:
Main Authors: | Yanan He (Author), Wei Huang (Author), Chen Zhang (Author), Lumeng Chen (Author), Runchun Xu (Author), Nan Li (Author), Fang Wang (Author), Li Han (Author), Ming Yang (Author), Dingkun Zhang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Type 2 Diabetes Complicated With Heart Failure: Research on Therapeutic Mechanism and Potential Drug Development Based on Insulin Signaling Pathway
by: Hui Ye, et al.
Published: (2022) -
Microwave technology: a novel approach to the transformation of natural metabolites
by: Qi Hu, et al.
Published: (2021) -
Bioinformatics identifies key genes and potential drugs for energy metabolism disorders in heart failure with dilated cardiomyopathy
by: Haixia Wang, et al.
Published: (2024) -
Shenmai Injection Improves Energy Metabolism in Patients With Heart Failure: A Randomized Controlled Trial
by: Shao-mei Wang, et al.
Published: (2020) -
The Potential Therapeutic Prospect of PANoptosis in Heart Failure
by: Jia Y, et al.
Published: (2024)